STOCK TITAN

Insulet Corp (PODD) EVP receives new stock options and RSU awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Insulet Corp EVP and CCO Michael Panos received new equity awards. He was granted an employee stock option covering 7,255 shares of common stock at an exercise price of $207.04 per share, expiring on April 1, 2036. These non-qualified stock options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

He also received 2,777 restricted stock units that vest in substantially equal installments on each of the first, second and third anniversaries of the grant date and are settled one-for-one in common shares. Following these grants, he directly holds 2,782 shares of common stock and 7,255 stock options.

Positive

  • None.

Negative

  • None.
Insider Panos Michael
Role EVP and CCO
Type Security Shares Price Value
Grant/Award Employee Stock Option (Right to Buy) 7,255 $0.00 --
Grant/Award Common Stock 2,777 $0.00 --
Holdings After Transaction: Employee Stock Option (Right to Buy) — 7,255 shares (Direct); Common Stock — 2,782 shares (Direct)
Footnotes (1)
  1. Restricted stock unit ("RSU") award. RSUs vest in substantially equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis. Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.
Stock options granted 7,255 options Employee Stock Option grant on April 1, 2026
Option exercise price $207.04 per share Non-qualified stock option strike price
Option expiration April 1, 2036 Non-qualified stock option expiration date
RSUs granted 2,777 RSUs Restricted stock unit award on April 1, 2026
Common shares after grant 2,782 shares Direct common stock holdings following RSU grant
Options after grant 7,255 options Direct option holdings following grant
Restricted stock unit ("RSU") award financial
"Restricted stock unit ("RSU") award. RSUs vest in substantially equal installments"
Non-Qualified Stock Option ("Option") Award financial
"Non-Qualified Stock Option ("Option") Award. The Options become exercisable"
Employee Stock Option (Right to Buy) financial
"security_title": "Employee Stock Option (Right to Buy)"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Panos Michael

(Last)(First)(Middle)
C/O INSULET CORPORATION
100 NAGOG PARK

(Street)
ACTON MASSACHUSETTS 01720

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
INSULET CORP [ PODD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP and CCO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/01/2026A2,777(1)A$02,782D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$207.0404/01/2026A7,255 (2)04/01/2036Common Stock7,255$07,255D
Explanation of Responses:
1. Restricted stock unit ("RSU") award. RSUs vest in substantially equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.
2. Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.
/s/ Patricia K. Dolan, attorney-in-fact04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Insulet (PODD) grant to EVP and CCO Michael Panos?

Insulet granted Michael Panos 7,255 non-qualified stock options with a $207.04 exercise price and 2,777 restricted stock units. Both awards were made on April 1, 2026 as part of his compensation package.

How do the new stock options for Insulet (PODD) executive Michael Panos vest?

The 7,255 non-qualified stock options vest in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date. This staggered schedule ties long-term incentives to multi-year service with Insulet.

What is the vesting schedule for Michael Panos’s RSUs at Insulet (PODD)?

The 2,777 restricted stock units vest in substantially equal installments on each of the first, second and third anniversaries of the grant date. Each vested RSU is settled in one share of Insulet common stock.

What is the exercise price and expiration date of the new Insulet (PODD) stock options?

The newly granted non-qualified stock options have an exercise price of $207.04 per share and expire on April 1, 2036. They can be exercised only after vesting in four annual installments.

How many Insulet (PODD) shares does Michael Panos hold after these grants?

After the April 1, 2026 equity awards, Michael Panos directly holds 2,782 shares of Insulet common stock and 7,255 stock options. These positions reflect his updated direct ownership reported in the Form 4 filing.
Insulet Corp

NASDAQ:PODD

View PODD Stock Overview

PODD Rankings

PODD Latest News

PODD Latest SEC Filings

PODD Stock Data

14.38B
70.13M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ACTON